Company / Profit Margin
MADRIGAL PHARMACEUTICALS, INC. Profit Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-30.1%
FY2025
5-year range
-258.6% / -30.1%
FY2024-FY2025
Trend
+88.4%
vs FY2024
Sector context
#80 of 146
Health Care
What the data says
At -30.1%, MADRIGAL PHARMACEUTICALS, INC.'s profit margin ranks #80 of 146 in the Health Care sector.
Based on SEC 10-K filings.
-30.1% in FY2025.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#80 of 146 in Health CareTop 55% of 146This company -30.1% Sector average -796.3%
▼
+96.2% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 88.4% year-over-year.
- Currently 766.2pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -30.1% | +88.4% |
| FY2024 | -258.6% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026